
The global GPCR Assay Services market size is predicted to grow from US$ 794 million in 2025 to US$ 1175 million in 2031; it is expected to grow at a CAGR of 6.7% from 2025 to 2031.
GPCR assay services refer to the specialized laboratory services offered by contract research organizations (CROs) or research facilities to conduct assays and experiments related to G Protein-Coupled Receptors (GPCRs). These services are commonly used in drug discovery and pharmacological research to assess the activity of GPCRs and identify potential drug candidates that can interact with these receptors. GPCRs are a large family of cell membrane proteins involved in a wide range of physiological processes, and they are targets for a significant portion of pharmaceutical drugs.
Growth in Drug Discovery: The pharmaceutical industry continued to invest in drug discovery, and GPCR targets remained a significant focus due to their involvement in various diseases and physiological processes. This drove demand for GPCR assay services to identify potential drug candidates.
High-Throughput Screening (HTS): The use of high-throughput screening techniques in GPCR assays was on the rise. HTS allows researchers to rapidly test large compound libraries, accelerating the drug discovery process.
Biophysical Assays: There was an increasing emphasis on developing biophysical assays that provide insights into GPCR conformational changes and interactions with ligands. These assays are critical for understanding receptor behavior and drug binding.
Functional Assays: GPCR assay services continued to evolve with a focus on functional assays that assess the signaling pathways activated by GPCRs upon ligand binding. This included the use of more physiologically relevant cell-based assays.
The 鈥淕PCR Assay Services Industry Forecast鈥 looks at past sales and reviews total world GPCR Assay Services sales in 2024, providing a comprehensive analysis by region and market sector of projected GPCR Assay Services sales for 2025 through 2031. With GPCR Assay Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GPCR Assay Services industry.
This Insight Report provides a comprehensive analysis of the global GPCR Assay Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on GPCR Assay Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥 unique position in an accelerating global GPCR Assay Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GPCR Assay Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GPCR Assay Services.
This report presents a comprehensive overview, market shares, and growth opportunities of GPCR Assay Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
尾-arrestin Recruitment
Ca2+
cAMP
DAG
Segmentation by Application:
Oncology
Cardiovascular System
Central Nervous System
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
PerkinElmer
Merck
Molecular Devices
Promega
Cisbio
Discoverx
Enzo Life Sciences
Pharmaron
Innoprot
Euroscreen
ArcoScreen
Profacgen
Creative BioMart
Hamamatsu Photonics
Reaction Biology
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global GPCR Assay Services 麻豆原创 Size (2020-2031)
2.1.2 GPCR Assay Services 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for GPCR Assay Services by Country/Region (2020, 2024 & 2031)
2.2 GPCR Assay Services Segment by Type
2.2.1 尾-arrestin Recruitment
2.2.2 Ca2+
2.2.3 cAMP
2.2.4 DAG
2.3 GPCR Assay Services 麻豆原创 Size by Type
2.3.1 GPCR Assay Services 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global GPCR Assay Services 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 GPCR Assay Services Segment by Application
2.4.1 Oncology
2.4.2 Cardiovascular System
2.4.3 Central Nervous System
2.4.4 Others
2.5 GPCR Assay Services 麻豆原创 Size by Application
2.5.1 GPCR Assay Services 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global GPCR Assay Services 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 GPCR Assay Services 麻豆原创 Size by Player
3.1 GPCR Assay Services 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global GPCR Assay Services Revenue by Player (2020-2025)
3.1.2 Global GPCR Assay Services Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global GPCR Assay Services Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GPCR Assay Services by Region
4.1 GPCR Assay Services 麻豆原创 Size by Region (2020-2025)
4.2 Global GPCR Assay Services Annual Revenue by Country/Region (2020-2025)
4.3 Americas GPCR Assay Services 麻豆原创 Size Growth (2020-2025)
4.4 APAC GPCR Assay Services 麻豆原创 Size Growth (2020-2025)
4.5 Europe GPCR Assay Services 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa GPCR Assay Services 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas GPCR Assay Services 麻豆原创 Size by Country (2020-2025)
5.2 Americas GPCR Assay Services 麻豆原创 Size by Type (2020-2025)
5.3 Americas GPCR Assay Services 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GPCR Assay Services 麻豆原创 Size by Region (2020-2025)
6.2 APAC GPCR Assay Services 麻豆原创 Size by Type (2020-2025)
6.3 APAC GPCR Assay Services 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe GPCR Assay Services 麻豆原创 Size by Country (2020-2025)
7.2 Europe GPCR Assay Services 麻豆原创 Size by Type (2020-2025)
7.3 Europe GPCR Assay Services 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa GPCR Assay Services by Region (2020-2025)
8.2 Middle East & Africa GPCR Assay Services 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa GPCR Assay Services 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global GPCR Assay Services 麻豆原创 Forecast
10.1 Global GPCR Assay Services Forecast by Region (2026-2031)
10.1.1 Global GPCR Assay Services Forecast by Region (2026-2031)
10.1.2 Americas GPCR Assay Services Forecast
10.1.3 APAC GPCR Assay Services Forecast
10.1.4 Europe GPCR Assay Services Forecast
10.1.5 Middle East & Africa GPCR Assay Services Forecast
10.2 Americas GPCR Assay Services Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 GPCR Assay Services Forecast
10.2.2 Canada 麻豆原创 GPCR Assay Services Forecast
10.2.3 Mexico 麻豆原创 GPCR Assay Services Forecast
10.2.4 Brazil 麻豆原创 GPCR Assay Services Forecast
10.3 APAC GPCR Assay Services Forecast by Region (2026-2031)
10.3.1 China GPCR Assay Services 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 GPCR Assay Services Forecast
10.3.3 Korea 麻豆原创 GPCR Assay Services Forecast
10.3.4 Southeast Asia 麻豆原创 GPCR Assay Services Forecast
10.3.5 India 麻豆原创 GPCR Assay Services Forecast
10.3.6 Australia 麻豆原创 GPCR Assay Services Forecast
10.4 Europe GPCR Assay Services Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 GPCR Assay Services Forecast
10.4.2 France 麻豆原创 GPCR Assay Services Forecast
10.4.3 UK 麻豆原创 GPCR Assay Services Forecast
10.4.4 Italy 麻豆原创 GPCR Assay Services Forecast
10.4.5 Russia 麻豆原创 GPCR Assay Services Forecast
10.5 Middle East & Africa GPCR Assay Services Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 GPCR Assay Services Forecast
10.5.2 South Africa 麻豆原创 GPCR Assay Services Forecast
10.5.3 Israel 麻豆原创 GPCR Assay Services Forecast
10.5.4 Turkey 麻豆原创 GPCR Assay Services Forecast
10.6 Global GPCR Assay Services Forecast by Type (2026-2031)
10.7 Global GPCR Assay Services Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 GPCR Assay Services Forecast
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific GPCR Assay Services Product Offered
11.1.3 Thermo Fisher Scientific GPCR Assay Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 PerkinElmer
11.2.1 PerkinElmer Company Information
11.2.2 PerkinElmer GPCR Assay Services Product Offered
11.2.3 PerkinElmer GPCR Assay Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 PerkinElmer Main Business Overview
11.2.5 PerkinElmer Latest Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck GPCR Assay Services Product Offered
11.3.3 Merck GPCR Assay Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Merck Main Business Overview
11.3.5 Merck Latest Developments
11.4 Molecular Devices
11.4.1 Molecular Devices Company Information
11.4.2 Molecular Devices GPCR Assay Services Product Offered
11.4.3 Molecular Devices GPCR Assay Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Molecular Devices Main Business Overview
11.4.5 Molecular Devices Latest Developments
11.5 Promega
11.5.1 Promega Company Information
11.5.2 Promega GPCR Assay Services Product Offered
11.5.3 Promega GPCR Assay Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Promega Main Business Overview
11.5.5 Promega Latest Developments
11.6 Cisbio
11.6.1 Cisbio Company Information
11.6.2 Cisbio GPCR Assay Services Product Offered
11.6.3 Cisbio GPCR Assay Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Cisbio Main Business Overview
11.6.5 Cisbio Latest Developments
11.7 Discoverx
11.7.1 Discoverx Company Information
11.7.2 Discoverx GPCR Assay Services Product Offered
11.7.3 Discoverx GPCR Assay Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Discoverx Main Business Overview
11.7.5 Discoverx Latest Developments
11.8 Enzo Life Sciences
11.8.1 Enzo Life Sciences Company Information
11.8.2 Enzo Life Sciences GPCR Assay Services Product Offered
11.8.3 Enzo Life Sciences GPCR Assay Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Enzo Life Sciences Main Business Overview
11.8.5 Enzo Life Sciences Latest Developments
11.9 Pharmaron
11.9.1 Pharmaron Company Information
11.9.2 Pharmaron GPCR Assay Services Product Offered
11.9.3 Pharmaron GPCR Assay Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Pharmaron Main Business Overview
11.9.5 Pharmaron Latest Developments
11.10 Innoprot
11.10.1 Innoprot Company Information
11.10.2 Innoprot GPCR Assay Services Product Offered
11.10.3 Innoprot GPCR Assay Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Innoprot Main Business Overview
11.10.5 Innoprot Latest Developments
11.11 Euroscreen
11.11.1 Euroscreen Company Information
11.11.2 Euroscreen GPCR Assay Services Product Offered
11.11.3 Euroscreen GPCR Assay Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Euroscreen Main Business Overview
11.11.5 Euroscreen Latest Developments
11.12 ArcoScreen
11.12.1 ArcoScreen Company Information
11.12.2 ArcoScreen GPCR Assay Services Product Offered
11.12.3 ArcoScreen GPCR Assay Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 ArcoScreen Main Business Overview
11.12.5 ArcoScreen Latest Developments
11.13 Profacgen
11.13.1 Profacgen Company Information
11.13.2 Profacgen GPCR Assay Services Product Offered
11.13.3 Profacgen GPCR Assay Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Profacgen Main Business Overview
11.13.5 Profacgen Latest Developments
11.14 Creative BioMart
11.14.1 Creative BioMart Company Information
11.14.2 Creative BioMart GPCR Assay Services Product Offered
11.14.3 Creative BioMart GPCR Assay Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Creative BioMart Main Business Overview
11.14.5 Creative BioMart Latest Developments
11.15 Hamamatsu Photonics
11.15.1 Hamamatsu Photonics Company Information
11.15.2 Hamamatsu Photonics GPCR Assay Services Product Offered
11.15.3 Hamamatsu Photonics GPCR Assay Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 Hamamatsu Photonics Main Business Overview
11.15.5 Hamamatsu Photonics Latest Developments
11.16 Reaction Biology
11.16.1 Reaction Biology Company Information
11.16.2 Reaction Biology GPCR Assay Services Product Offered
11.16.3 Reaction Biology GPCR Assay Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 Reaction Biology Main Business Overview
11.16.5 Reaction Biology Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
